References
- Alam HB, Burris D, DaCorta JA, Rhee P. Hemorrhage control in the battlefield: role of new hemostatic agents. Mil Med 2005;170:63–69.
- Carr ME Jr. Monitoring of hemostasis in combat trauma patients. Mil Med 2004;169:11–15.
- Clifford CC. Treating traumatic bleeding in a combat setting. Mil Med 2004;169:8–10.
- Martinowitz U, Zaarur M, Yaron BL, et al. Treating traumatic bleeding in a combat setting: possible role of recombinant activated factor VII. Mil Med 2004;169:16–18.
- Cox ED, Schreiber MA, McManus J, et al. New hemostatic agents in the combat setting. Transfusion 2009;49:248S–255S.
- Neuffer MC, McDivitt J, Rose D, et al. Hemostatic dressings for the first responder: a review. Mil Med 2004;169:716–720.
- Wedmore I, McManus JG, Pusateri AE, Holcomb JB. A special report on the chitosan-based hemostatic dressing: experience in current combat operations. J Trauma 2006;60:655–658.
- King DR. Thirty consecutive uses of a hemostatic bandage at a US Army combat support hospital and forward surgical team in operation Iraqi freedom. J Trauma 2011;71:1775–1778.
- Dorandeu F, Mikler JR, Thiermann H, et al. Swine models in the design of more effective medical countermeasures against organophosphorus poisoning. Toxicology 2007;233:128–144.
- Simon GA, Maibach HI. The pig as an experimental animal model of percutaneous permeation in man: Qualitative and quantitative observations—an overview. Skin Pharmacol Appl Skin Physiol 2000;13:229–234.
- Dalton CH, Hall CA, Lydon HL, et al. Development of haemostatic decontaminants for treatment of wounds contaminated with chemical warfare agents. 2: evaluation of in vitro topical decontamination efficacy using undamaged skin. J Appl Toxicol 2015;35:543–550.
- Hall CA, Lydon HL, Dalton CH, et al. Development of haemostatic decontaminants for the treatment of wounds contaminated with chemical warfare agents. 1: evaluation of in vitro clotting efficacy in the presence of certain contaminants. J Appl Toxicol 2015;35:536–542.
- Lydon HL, Hall CA, Dalton CH, et al. Development of haemostatic decontaminants for treatment of wounds contaminated with chemical warfare agents. 3: evaluation of in vitro topical decontamination efficacy using damaged skin. J Appl Toxicol 2017;37:976–984.
- Ellman GL, Courtney KD, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961;7:88–95.
- Moore PA. Preparation of whole blood for liquid scintillation counting. Clin Chem 1981;27:609–611.
- Bush JA, Jensen WN, Cartwright GE, Wintrobe MM. Blood volume studies in normal and anemic swine. Am J Physiol 1955;181:9–14.
- Chilcott RP, Dalton CH, Ashley Z, et al. Evaluation of barrier creams against sulphur mustard: (II) In vivo and in vitro studies using the domestic white pig. Cutan Ocul Toxicol 2007;26:235–247.
- Duncan EJ, Brown A, Lundy P, et al. Site-specific percutaneous absorption of methyl salicylate and VX in domestic swine. J Appl Toxicol 2002;22:141–148.
- Hall CA, Lydon HL, Dalton CH, et al. The percutaneous toxicokinetics of sulphur mustard in a damaged skin porcine model and the evaluation of WoundStat™ as a topical decontaminant. J Appl Toxicol 2017;37:1036–1045.
- Dalton CH, Hall CA, Lydon HL, et al. Absorption of GD through damaged and undamaged pig skin in vitro. Twelfth International Perspectives in Percutaneous Penetration Conference, Vol. 12; 2010; Cardiff, UK; 121 p.
- Joosen MJ, van der Schans MJ, Kuijpers WC, et al. Timing of decontamination and treatment in case of percutaneous VX poisoning: a mini review. Chem Biol Interact 2013;203:149–153.